FIELD: biotechnology.
SUBSTANCE: biologically active peptide is obtained, which has curative effect against Alzheimer disease, and consisting of the amino acid sequence Ala-Trp-Lys-Val-Leu-Ser-Pro-Gln-Gly-Gly-Gly-Pro-Trp-Asp-Ser-Val-Ala.
EFFECT: invention enables to use the resulting peptide to create a drug effective in the therapy of Alzheimer disease.
1 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE HAVING THERAPEUTIC EFFECT AGAINST ALZHEIMER'S DISEASE | 2018 |
|
RU2677296C2 |
| PEPTIDE WITH TREATMENT ACTION AGAINST ALZHEIMER'S DISEASE | 2016 |
|
RU2626972C2 |
| PEPTIDE WITH PROTECTIVE ACTION AGAINST ALZHEIMER'S DISEASE | 2008 |
|
RU2372355C1 |
| PEPTIDE STIMULATING FORMATION OF SPECIFIC ANTIBODIES AGAINST OLIGOMERIC FORM OF NUCLEOPHOSMIN IN TUMOUR CELLS | 2009 |
|
RU2401275C1 |
| PEPTIDE STIMULATING FORMATION OF SPECIFIC ANTIBODIES HAVING EFFECT ON SURVIVIN IN TUMOUR TISSUE | 2009 |
|
RU2396277C1 |
| PEPTIDE STIMULATING FORMATION OF SPECIFIC ANTIBODIES AGAINST MONOMERIC FORM OF NUCLEOPHOSMIN IN TUMOUR CELLS | 2009 |
|
RU2401274C1 |
| METHOD FOR PRODUCING PEPTIDE EXENATIDE | 2011 |
|
RU2458066C1 |
| CODING THE HYBRID PROTEIN RECOMBINANT PLASMID DNA PERIG-PGS, ABLE TO AUTOCATALIC SPLITTING WITH FORMATION OF THE PIGASTINE ANTI-ANGIOGENIC PEPTIDE - DERIVATIVE OF THE HUMAN PIGMENTAL EPITHELY GROWTH FACTOR FRAGMENT [44-77], STRAIN ESCHERICHIA COLI BL21(DE3)/PERIG-PGS - PRODUCER OF THE SAID PROTEIN, AND THE RECOMBINANT ANTI-ANGIOGENIC PEPTIDE PRODUCTION METHOD | 2017 |
|
RU2664199C1 |
| CATIONIC PEPTIDE EXHIBITING ANTIBACTERIAL PROPERTIES | 2021 |
|
RU2778856C1 |
| FAMILY OF PEPTIDES POSSESSING ANALGESIC ACTIVITY | 2005 |
|
RU2286169C1 |
